nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—chronic obstructive pulmonary disease	0.227	0.542	CbGaD
Maprotiline—HTR2A—chronic obstructive pulmonary disease	0.192	0.458	CbGaD
Maprotiline—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.104	0.269	CbGbCtD
Maprotiline—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0667	0.172	CbGbCtD
Maprotiline—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0581	0.149	CbGbCtD
Maprotiline—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0535	0.138	CbGbCtD
Maprotiline—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0226	0.0581	CbGbCtD
Maprotiline—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0219	0.0563	CbGbCtD
Maprotiline—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0219	0.0563	CbGbCtD
Maprotiline—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0195	0.0502	CbGbCtD
Maprotiline—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0103	0.0266	CbGbCtD
Maprotiline—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00976	0.0251	CbGbCtD
Maprotiline—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00733	0.259	CbGeAlD
Maprotiline—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00427	0.151	CbGeAlD
Maprotiline—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00266	0.094	CbGeAlD
Maprotiline—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000923	0.0326	CbGeAlD
Maprotiline—Sertraline—SLC6A4—chronic obstructive pulmonary disease	0.000861	0.211	CrCbGaD
Maprotiline—Sertraline—CYP1A2—chronic obstructive pulmonary disease	0.000784	0.192	CrCbGaD
Maprotiline—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000745	0.0263	CbGeAlD
Maprotiline—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000718	0.0253	CbGeAlD
Maprotiline—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000679	0.024	CbGeAlD
Maprotiline—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000632	0.0223	CbGeAlD
Maprotiline—CHRM1—trachea—chronic obstructive pulmonary disease	0.000623	0.022	CbGeAlD
Maprotiline—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000607	0.0214	CbGeAlD
Maprotiline—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000578	0.0204	CbGeAlD
Maprotiline—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000572	0.0202	CbGeAlD
Maprotiline—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000536	0.0189	CbGeAlD
Maprotiline—HTR7—trachea—chronic obstructive pulmonary disease	0.00053	0.0187	CbGeAlD
Maprotiline—ORM1—lung—chronic obstructive pulmonary disease	0.000527	0.0186	CbGeAlD
Maprotiline—Protriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000494	0.121	CrCbGaD
Maprotiline—SLC6A3—lung—chronic obstructive pulmonary disease	0.00049	0.0173	CbGeAlD
Maprotiline—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000472	0.0167	CbGeAlD
Maprotiline—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000448	0.0158	CbGeAlD
Maprotiline—CHRM1—lung—chronic obstructive pulmonary disease	0.000447	0.0158	CbGeAlD
Maprotiline—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000431	0.0152	CbGeAlD
Maprotiline—HRH1—trachea—chronic obstructive pulmonary disease	0.000396	0.014	CbGeAlD
Maprotiline—SLC6A2—lung—chronic obstructive pulmonary disease	0.000395	0.014	CbGeAlD
Maprotiline—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000394	0.0139	CbGeAlD
Maprotiline—HTR7—lung—chronic obstructive pulmonary disease	0.000381	0.0135	CbGeAlD
Maprotiline—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00036	0.0127	CbGeAlD
Maprotiline—DRD2—lung—chronic obstructive pulmonary disease	0.00036	0.0127	CbGeAlD
Maprotiline—HTR2A—trachea—chronic obstructive pulmonary disease	0.000331	0.0117	CbGeAlD
Maprotiline—CYP1A2—lung—chronic obstructive pulmonary disease	0.000304	0.0107	CbGeAlD
Maprotiline—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000293	0.0104	CbGeAlD
Maprotiline—HRH1—lung—chronic obstructive pulmonary disease	0.000285	0.01	CbGeAlD
Maprotiline—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000256	0.00212	CcSEcCtD
Maprotiline—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00211	CcSEcCtD
Maprotiline—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00209	CcSEcCtD
Maprotiline—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000252	0.00208	CcSEcCtD
Maprotiline—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00206	CcSEcCtD
Maprotiline—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000249	0.00206	CcSEcCtD
Maprotiline—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00204	CcSEcCtD
Maprotiline—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00204	CcSEcCtD
Maprotiline—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00202	CcSEcCtD
Maprotiline—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00202	CcSEcCtD
Maprotiline—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.002	CcSEcCtD
Maprotiline—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000242	0.002	CcSEcCtD
Maprotiline—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000242	0.002	CcSEcCtD
Maprotiline—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.002	CcSEcCtD
Maprotiline—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00199	CcSEcCtD
Maprotiline—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.00198	CcSEcCtD
Maprotiline—HTR2A—lung—chronic obstructive pulmonary disease	0.000238	0.00839	CbGeAlD
Maprotiline—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00196	CcSEcCtD
Maprotiline—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00196	CcSEcCtD
Maprotiline—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000235	0.00194	CcSEcCtD
Maprotiline—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00193	CcSEcCtD
Maprotiline—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00193	CcSEcCtD
Maprotiline—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00193	CcSEcCtD
Maprotiline—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00191	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00023	0.0019	CcSEcCtD
Maprotiline—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00189	CcSEcCtD
Maprotiline—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00189	CcSEcCtD
Maprotiline—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00189	CcSEcCtD
Maprotiline—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00188	CcSEcCtD
Maprotiline—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00188	CcSEcCtD
Maprotiline—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00186	CcSEcCtD
Maprotiline—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00185	CcSEcCtD
Maprotiline—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00185	CcSEcCtD
Maprotiline—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00185	CcSEcCtD
Maprotiline—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00185	CcSEcCtD
Maprotiline—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00185	CcSEcCtD
Maprotiline—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00185	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00184	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00184	CcSEcCtD
Maprotiline—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00182	CcSEcCtD
Maprotiline—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00182	CcSEcCtD
Maprotiline—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00182	CcSEcCtD
Maprotiline—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Maprotiline—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00181	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00181	CcSEcCtD
Maprotiline—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000218	0.0018	CcSEcCtD
Maprotiline—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000217	0.0532	CrCbGaD
Maprotiline—ABCB1—trachea—chronic obstructive pulmonary disease	0.000217	0.00765	CbGeAlD
Maprotiline—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.00178	CcSEcCtD
Maprotiline—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000215	0.00178	CcSEcCtD
Maprotiline—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00178	CcSEcCtD
Maprotiline—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00177	CcSEcCtD
Maprotiline—Infection—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00177	CcSEcCtD
Maprotiline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00175	CcSEcCtD
Maprotiline—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00175	CcSEcCtD
Maprotiline—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00175	CcSEcCtD
Maprotiline—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00175	CcSEcCtD
Maprotiline—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000211	0.00174	CcSEcCtD
Maprotiline—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00174	CcSEcCtD
Maprotiline—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00174	CcSEcCtD
Maprotiline—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00174	CcSEcCtD
Maprotiline—Infection—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00173	CcSEcCtD
Maprotiline—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00173	CcSEcCtD
Maprotiline—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00173	CcSEcCtD
Maprotiline—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00173	CcSEcCtD
Maprotiline—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00171	CcSEcCtD
Maprotiline—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00171	CcSEcCtD
Maprotiline—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00171	CcSEcCtD
Maprotiline—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00171	CcSEcCtD
Maprotiline—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00169	CcSEcCtD
Maprotiline—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00168	CcSEcCtD
Maprotiline—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00167	CcSEcCtD
Maprotiline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00166	CcSEcCtD
Maprotiline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00166	CcSEcCtD
Maprotiline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.00165	CcSEcCtD
Maprotiline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00165	CcSEcCtD
Maprotiline—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00165	CcSEcCtD
Maprotiline—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00165	CcSEcCtD
Maprotiline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00164	CcSEcCtD
Maprotiline—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00163	CcSEcCtD
Maprotiline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00162	CcSEcCtD
Maprotiline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00161	CcSEcCtD
Maprotiline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00161	CcSEcCtD
Maprotiline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000194	0.0016	CcSEcCtD
Maprotiline—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00159	CcSEcCtD
Maprotiline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00158	CcSEcCtD
Maprotiline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00158	CcSEcCtD
Maprotiline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00158	CcSEcCtD
Maprotiline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00157	CcSEcCtD
Maprotiline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00157	CcSEcCtD
Maprotiline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00157	CcSEcCtD
Maprotiline—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000189	0.0465	CrCbGaD
Maprotiline—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00157	CcSEcCtD
Maprotiline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000189	0.00156	CcSEcCtD
Maprotiline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00155	CcSEcCtD
Maprotiline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00155	CcSEcCtD
Maprotiline—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00154	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00154	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00154	CcSEcCtD
Maprotiline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00153	CcSEcCtD
Maprotiline—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00153	CcSEcCtD
Maprotiline—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00153	CcSEcCtD
Maprotiline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00152	CcSEcCtD
Maprotiline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00152	CcSEcCtD
Maprotiline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00152	CcSEcCtD
Maprotiline—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00152	CcSEcCtD
Maprotiline—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00151	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00151	CcSEcCtD
Maprotiline—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000182	0.0015	CcSEcCtD
Maprotiline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00149	CcSEcCtD
Maprotiline—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00149	CcSEcCtD
Maprotiline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00018	0.00149	CcSEcCtD
Maprotiline—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00148	CcSEcCtD
Maprotiline—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00148	CcSEcCtD
Maprotiline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00148	CcSEcCtD
Maprotiline—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00148	CcSEcCtD
Maprotiline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.00147	CcSEcCtD
Maprotiline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.00147	CcSEcCtD
Maprotiline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00147	CcSEcCtD
Maprotiline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00147	CcSEcCtD
Maprotiline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.00147	CcSEcCtD
Maprotiline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00146	CcSEcCtD
Maprotiline—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00146	CcSEcCtD
Maprotiline—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00146	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00145	CcSEcCtD
Maprotiline—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Maprotiline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00144	CcSEcCtD
Maprotiline—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.0423	CrCbGaD
Maprotiline—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00143	CcSEcCtD
Maprotiline—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00143	CcSEcCtD
Maprotiline—Desipramine—ADRB2—chronic obstructive pulmonary disease	0.000172	0.0422	CrCbGaD
Maprotiline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00141	CcSEcCtD
Maprotiline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00141	CcSEcCtD
Maprotiline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Maprotiline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Maprotiline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Maprotiline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00141	CcSEcCtD
Maprotiline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00017	0.0014	CcSEcCtD
Maprotiline—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Maprotiline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Maprotiline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Maprotiline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Maprotiline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Maprotiline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00139	CcSEcCtD
Maprotiline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Maprotiline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Maprotiline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Maprotiline—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	0.000167	0.0409	CrCbGaD
Maprotiline—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00137	CcSEcCtD
Maprotiline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00134	CcSEcCtD
Maprotiline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00133	CcSEcCtD
Maprotiline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00133	CcSEcCtD
Maprotiline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00131	CcSEcCtD
Maprotiline—Desipramine—SLC6A4—chronic obstructive pulmonary disease	0.000156	0.0383	CrCbGaD
Maprotiline—ABCB1—lung—chronic obstructive pulmonary disease	0.000156	0.0055	CbGeAlD
Maprotiline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00128	CcSEcCtD
Maprotiline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00128	CcSEcCtD
Maprotiline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Maprotiline—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Maprotiline—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00126	CcSEcCtD
Maprotiline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00125	CcSEcCtD
Maprotiline—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00123	CcSEcCtD
Maprotiline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Maprotiline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Maprotiline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00121	CcSEcCtD
Maprotiline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00121	CcSEcCtD
Maprotiline—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	0.000146	0.0357	CrCbGaD
Maprotiline—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000145	0.0012	CcSEcCtD
Maprotiline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00119	CcSEcCtD
Maprotiline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00119	CcSEcCtD
Maprotiline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00118	CcSEcCtD
Maprotiline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00118	CcSEcCtD
Maprotiline—Desipramine—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.0349	CrCbGaD
Maprotiline—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Maprotiline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00115	CcSEcCtD
Maprotiline—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00113	CcSEcCtD
Maprotiline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00113	CcSEcCtD
Maprotiline—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00113	CcSEcCtD
Maprotiline—Rash—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00112	CcSEcCtD
Maprotiline—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00112	CcSEcCtD
Maprotiline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00112	CcSEcCtD
Maprotiline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00112	CcSEcCtD
Maprotiline—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00112	CcSEcCtD
Maprotiline—Headache—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00112	CcSEcCtD
Maprotiline—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00112	CcSEcCtD
Maprotiline—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00111	CcSEcCtD
Maprotiline—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00111	CcSEcCtD
Maprotiline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00111	CcSEcCtD
Maprotiline—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00111	CcSEcCtD
Maprotiline—Rash—Montelukast—chronic obstructive pulmonary disease	0.000133	0.0011	CcSEcCtD
Maprotiline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000133	0.0011	CcSEcCtD
Maprotiline—Imipramine—SLC6A4—chronic obstructive pulmonary disease	0.000132	0.0325	CrCbGaD
Maprotiline—Headache—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00109	CcSEcCtD
Maprotiline—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00108	CcSEcCtD
Maprotiline—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Maprotiline—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00108	CcSEcCtD
Maprotiline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00107	CcSEcCtD
Maprotiline—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00106	CcSEcCtD
Maprotiline—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00106	CcSEcCtD
Maprotiline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00106	CcSEcCtD
Maprotiline—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00106	CcSEcCtD
Maprotiline—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00106	CcSEcCtD
Maprotiline—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00105	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00104	CcSEcCtD
Maprotiline—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00104	CcSEcCtD
Maprotiline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00102	CcSEcCtD
Maprotiline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Maprotiline—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000998	CcSEcCtD
Maprotiline—Imipramine—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.0296	CrCbGaD
Maprotiline—Desipramine—HTR2A—chronic obstructive pulmonary disease	0.00012	0.0294	CrCbGaD
Maprotiline—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000981	CcSEcCtD
Maprotiline—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000964	CcSEcCtD
Maprotiline—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000948	CcSEcCtD
Maprotiline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000941	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000932	CcSEcCtD
Maprotiline—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000921	CcSEcCtD
Maprotiline—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000915	CcSEcCtD
Maprotiline—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000895	CcSEcCtD
Maprotiline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000881	CcSEcCtD
Maprotiline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000872	CcSEcCtD
Maprotiline—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000871	CcSEcCtD
Maprotiline—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000866	CcSEcCtD
Maprotiline—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000858	CcSEcCtD
Maprotiline—Imipramine—HTR2A—chronic obstructive pulmonary disease	0.000102	0.025	CrCbGaD
Maprotiline—Nortriptyline—ALB—chronic obstructive pulmonary disease	9.96e-05	0.0245	CrCbGaD
Maprotiline—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000809	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.61e-05	0.000794	CcSEcCtD
Maprotiline—Agitation—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000789	CcSEcCtD
Maprotiline—Syncope—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.00077	CcSEcCtD
Maprotiline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	9.26e-05	0.000766	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000754	CcSEcCtD
Maprotiline—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.99e-05	0.000744	CcSEcCtD
Maprotiline—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000741	CcSEcCtD
Maprotiline—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000728	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.78e-05	0.000726	CcSEcCtD
Maprotiline—Oedema—Prednisone—chronic obstructive pulmonary disease	8.47e-05	0.000701	CcSEcCtD
Maprotiline—Infection—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.000696	CcSEcCtD
Maprotiline—Shock—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000689	CcSEcCtD
Maprotiline—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.000687	CcSEcCtD
Maprotiline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000684	CcSEcCtD
Maprotiline—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.00068	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.000677	CcSEcCtD
Maprotiline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.71e-05	0.000638	CcSEcCtD
Maprotiline—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000634	CcSEcCtD
Maprotiline—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000629	CcSEcCtD
Maprotiline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000617	CcSEcCtD
Maprotiline—Rash—Prednisolone—chronic obstructive pulmonary disease	7.35e-05	0.000608	CcSEcCtD
Maprotiline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.35e-05	0.000607	CcSEcCtD
Maprotiline—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000604	CcSEcCtD
Maprotiline—Headache—Prednisolone—chronic obstructive pulmonary disease	7.3e-05	0.000604	CcSEcCtD
Maprotiline—Constipation—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000599	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000577	CcSEcCtD
Maprotiline—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000573	CcSEcCtD
Maprotiline—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.93e-05	0.000573	CcSEcCtD
Maprotiline—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000557	CcSEcCtD
Maprotiline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000554	CcSEcCtD
Maprotiline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000554	CcSEcCtD
Maprotiline—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000503	CcSEcCtD
Maprotiline—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.99e-05	0.000496	CcSEcCtD
Maprotiline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.000479	CcSEcCtD
Maprotiline—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000463	CcSEcCtD
Maprotiline—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.000445	CcSEcCtD
Maprotiline—Rash—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000442	CcSEcCtD
Maprotiline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000441	CcSEcCtD
Maprotiline—Headache—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000439	CcSEcCtD
Maprotiline—Nausea—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000416	CcSEcCtD
Maprotiline—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.24e-05	0.000319	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.23e-05	0.000318	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.22e-05	0.000315	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.000314	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.22e-05	0.000314	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.21e-05	0.000313	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.2e-05	0.000309	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000308	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.19e-05	0.000307	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.19e-05	0.000306	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.18e-05	0.000303	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.000303	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.17e-05	0.0003	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.16e-05	0.000299	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.000298	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.15e-05	0.000296	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.00029	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.12e-05	0.000288	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.11e-05	0.000285	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.1e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000282	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.00028	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.08e-05	0.000279	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.08e-05	0.000279	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.08e-05	0.000278	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.07e-05	0.000275	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.000271	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.00027	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.04e-05	0.000269	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.04e-05	0.000268	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.03e-05	0.000265	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1e-05	0.000259	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.92e-06	0.000256	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.86e-06	0.000254	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.85e-06	0.000254	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.74e-06	0.000251	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.59e-06	0.000247	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.57e-06	0.000247	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.54e-06	0.000246	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.51e-06	0.000245	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.5e-06	0.000245	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.48e-06	0.000244	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.47e-06	0.000244	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.44e-06	0.000243	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.41e-06	0.000243	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.37e-06	0.000242	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.34e-06	0.000241	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.29e-06	0.000239	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.25e-06	0.000238	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.08e-06	0.000234	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.06e-06	0.000233	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.91e-06	0.00023	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.89e-06	0.000229	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.86e-06	0.000228	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.84e-06	0.000228	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.82e-06	0.000227	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.75e-06	0.000226	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.61e-06	0.000222	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.58e-06	0.000221	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.53e-06	0.00022	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.48e-06	0.000219	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.46e-06	0.000218	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.44e-06	0.000218	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.36e-06	0.000215	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.23e-06	0.000212	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.21e-06	0.000212	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.18e-06	0.000211	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.17e-06	0.00021	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.15e-06	0.00021	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.09e-06	0.000208	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.08e-06	0.000208	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.99e-06	0.000206	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.74e-06	0.0002	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.74e-06	0.0002	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.69e-06	0.000198	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.68e-06	0.000198	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.53e-06	0.000194	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.52e-06	0.000194	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.47e-06	0.000193	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.41e-06	0.000191	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.4e-06	0.000191	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.39e-06	0.00019	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.37e-06	0.00019	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.35e-06	0.000189	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.34e-06	0.000189	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.33e-06	0.000189	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.33e-06	0.000189	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.31e-06	0.000188	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.29e-06	0.000188	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.29e-06	0.000188	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.27e-06	0.000187	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.25e-06	0.000187	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.22e-06	0.000186	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.13e-06	0.000184	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7e-06	0.00018	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.94e-06	0.000179	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.92e-06	0.000178	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.88e-06	0.000177	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.85e-06	0.000177	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.83e-06	0.000176	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.79e-06	0.000175	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.77e-06	0.000175	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.72e-06	0.000173	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.72e-06	0.000173	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.71e-06	0.000173	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.69e-06	0.000172	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.68e-06	0.000172	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.67e-06	0.000172	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.67e-06	0.000172	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.64e-06	0.000171	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.63e-06	0.000171	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.62e-06	0.000171	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.61e-06	0.00017	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.6e-06	0.00017	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.56e-06	0.000169	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.53e-06	0.000168	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.42e-06	0.000165	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.4e-06	0.000165	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.38e-06	0.000164	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.33e-06	0.000163	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.31e-06	0.000163	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.31e-06	0.000163	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.21e-06	0.00016	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.18e-06	0.000159	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.08e-06	0.000157	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.98e-06	0.000154	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.96e-06	0.000154	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.95e-06	0.000153	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.95e-06	0.000153	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.93e-06	0.000153	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.9e-06	0.000152	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.87e-06	0.000151	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.87e-06	0.000151	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.86e-06	0.000151	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.66e-06	0.000146	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.61e-06	0.000145	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.61e-06	0.000145	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.61e-06	0.000144	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.57e-06	0.000144	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	5.55e-06	0.000143	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.53e-06	0.000142	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.47e-06	0.000141	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.4e-06	0.000139	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.34e-06	0.000138	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	5.31e-06	0.000137	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.3e-06	0.000137	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.18e-06	0.000134	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.16e-06	0.000133	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.15e-06	0.000133	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.08e-06	0.000131	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.04e-06	0.00013	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5e-06	0.000129	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.92e-06	0.000127	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.9e-06	0.000126	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.89e-06	0.000126	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.88e-06	0.000126	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.87e-06	0.000126	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.83e-06	0.000124	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.77e-06	0.000123	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.76e-06	0.000123	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.75e-06	0.000122	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.69e-06	0.000121	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.68e-06	0.000121	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.68e-06	0.000121	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.67e-06	0.00012	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.65e-06	0.00012	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.63e-06	0.000119	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.61e-06	0.000119	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.57e-06	0.000118	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.56e-06	0.000117	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.55e-06	0.000117	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.54e-06	0.000117	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.48e-06	0.000115	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.47e-06	0.000115	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.45e-06	0.000115	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.44e-06	0.000114	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.4e-06	0.000113	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.37e-06	0.000113	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.36e-06	0.000112	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.35e-06	0.000112	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.28e-06	0.00011	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.18e-06	0.000108	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.14e-06	0.000107	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.14e-06	0.000107	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.1e-06	0.000106	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.04e-06	0.000104	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.97e-06	0.000102	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.96e-06	0.000102	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.95e-06	0.000102	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.94e-06	0.000102	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.9e-06	0.000101	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.84e-06	9.89e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.81e-06	9.81e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.78e-06	9.74e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.77e-06	9.71e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.76e-06	9.68e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.75e-06	9.65e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.72e-06	9.58e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.71e-06	9.56e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.65e-06	9.41e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.6e-06	9.27e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.59e-06	9.26e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.59e-06	9.24e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.57e-06	9.21e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.56e-06	9.18e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.53e-06	9.09e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.52e-06	9.08e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.49e-06	8.98e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.44e-06	8.88e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.41e-06	8.79e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.37e-06	8.68e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.34e-06	8.62e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.32e-06	8.55e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.29e-06	8.48e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.28e-06	8.45e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.23e-06	8.32e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.22e-06	8.3e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.21e-06	8.27e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.2e-06	8.24e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.18e-06	8.18e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.17e-06	8.16e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.15e-06	8.12e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.01e-06	7.76e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.96e-06	7.63e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.95e-06	7.62e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.95e-06	7.61e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.95e-06	7.59e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.94e-06	7.57e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.91e-06	7.49e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.9e-06	7.48e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.9e-06	7.47e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.89e-06	7.44e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.88e-06	7.42e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.85e-06	7.35e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.81e-06	7.25e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.81e-06	7.24e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.69e-06	6.93e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.57e-06	6.62e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.48e-06	6.39e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.44e-06	6.28e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.43e-06	6.27e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.42e-06	6.25e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.42e-06	6.23e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.39e-06	6.17e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.27e-06	5.84e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.23e-06	5.75e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.23e-06	5.74e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.22e-06	5.72e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.21e-06	5.7e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.19e-06	5.65e-05	CbGpPWpGaD
